Enabling Precision Medicine in Oncology, CNS & NASH to Power Advanced, Affordable Diagnostics for All

April 26-27, 2023 | London, UK

Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance & Commercialisation Path to Improve Clinical Decision Making & Patient Outcomes

Welcome to the 13th World Clinical Biomarker & CDx Europe Summit 2023!

The 13th Clinical Biomarkers & CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.

With two dedicated tracks on Biomarker Development and Drug-Dx Development & Commercialisation, this summit will be your ultimate guide to:


Understand European Biomarkers & CDx Development advancements in multiple disease areas in oncology and non-oncology indications


Discuss emerging functional assays and software technologies to advance and accelerate clinical and research programs aimed at personalising care for patients


Stay up to date with European specific regulatory, commercialisation and market access challenges and processes to successfully create your end-to-end biomarker & CDx strategy


Join forces to define a better framework for reimbursement of biomarkers that enable an equitable access to them for patients


Whether working in Oncology, NASH, Neuroscience, Inflammatory or cardiovascular diseases, come and join 250+ Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics Directors, Heads and VPs together with biomarker and CDx solution providers, regulatory experts and notified bodies for a well-rounded, all stakeholders included learning and networking experience that you can’t afford to miss out.

Attendence is Free for Biotech and Pharma

Snapshot of Our 2023 Expert Speaker Faculty:

Official 2023 Partners

Untitled design (9)

Other Events in the Series